These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25336460)

  • 1. Proteolytic processing and activation of Clostridium perfringens epsilon toxin by caprine small intestinal contents.
    Freedman JC; Li J; Uzal FA; McClane BA
    mBio; 2014 Oct; 5(5):e01994-14. PubMed ID: 25336460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into Clostridium perfringens epsilon toxin activation and action on the brain during enterotoxemia.
    Freedman JC; McClane BA; Uzal FA
    Anaerobe; 2016 Oct; 41():27-31. PubMed ID: 27321761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides.
    Minami J; Katayama S; Matsushita O; Matsushita C; Okabe A
    Microbiol Immunol; 1997; 41(7):527-35. PubMed ID: 9272698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a lambda toxin-negative Clostridium perfringens strain that processes and activates epsilon prototoxin intracellularly.
    Harkness JM; Li J; McClane BA
    Anaerobe; 2012 Oct; 18(5):546-52. PubMed ID: 22982043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium Perfringens Epsilon Toxin Binds to Membrane Lipids and Its Cytotoxic Action Depends on Sulfatide.
    Gil C; Dorca-Arévalo J; Blasi J
    PLoS One; 2015; 10(10):e0140321. PubMed ID: 26452234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies.
    Bokori-Brown M; Kokkinidou MC; Savva CG; Fernandes da Costa S; Naylor CE; Cole AR; Moss DS; Basak AK; Titball RW
    Protein Sci; 2013 May; 22(5):650-9. PubMed ID: 23504825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid residue Y196E substitution and C-terminal peptide synergistically alleviate the toxicity of Clostridium perfringens epsilon toxin.
    Yao W; Kang L; Gao S; Zhuang X; Zhang T; Yang H; Ji B; Xin W; Wang J
    Toxicon; 2015 Jun; 100():46-52. PubMed ID: 25912943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterotoxemia produced by lambda toxin-positive
    Acevedo HD; Schlesinger MS; Streitenberger N; Henderson E; Asin J; Beingesser J; Uzal FA
    J Vet Diagn Invest; 2023 Jul; 35(4):448-451. PubMed ID: 37212504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etx-Y71A as a non-toxic mutant of Clostridium perfringens epsilon toxin induces protective immunity in mice and sheep.
    Jiang Z; Chang J; Wang F; Qi Y; Li Y; Yu D; Yu L
    Vaccine; 2020 Sep; 38(42):6553-6561. PubMed ID: 32788135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of toxicity of Clostridium perfringens epsilon toxin.
    Bokori-Brown M; Savva CG; Fernandes da Costa SP; Naylor CE; Basak AK; Titball RW
    FEBS J; 2011 Dec; 278(23):4589-601. PubMed ID: 21518257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium perfringens epsilon toxin: the third most potent bacterial toxin known.
    Alves GG; Machado de Ávila RA; Chávez-Olórtegui CD; Lobato FC
    Anaerobe; 2014 Dec; 30():102-7. PubMed ID: 25234332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium perfringens epsilon prototoxin mutant rpETX
    Du J; Wang T; Xu L; Wang C; Liu Y; Pan C; Chen X; Zhu Z; Luo Y; Yin C
    Vaccine; 2023 Jul; 41(32):4762-4770. PubMed ID: 37357076
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kumar S; Behera SK; Gururaj K; Chaurasia A; Murmu S; Prabha R; Angadi UB; Pawaiya RS; Rai A
    J Biomol Struct Dyn; 2024 Mar; 42(5):2257-2269. PubMed ID: 37129165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between in vitro cytotoxicity and in vivo lethal activity in mice of epsilon toxin mutants from Clostridium perfringens.
    Dorca-Arévalo J; Pauillac S; Díaz-Hidalgo L; Martín-Satué M; Popoff MR; Blasi J
    PLoS One; 2014; 9(7):e102417. PubMed ID: 25013927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of four techniques for the detection of Clostridium perfringens type D epsilon toxin in intestinal contents and other body fluids of sheep and goats.
    Uzal FA; Kelly WR; Thomas R; Hornitzky M; Galea F
    J Vet Diagn Invest; 2003 Mar; 15(2):94-9. PubMed ID: 12661718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native or Proteolytically Activated NanI Sialidase Enhances the Binding and Cytotoxic Activity of Clostridium perfringens Enterotoxin and Beta Toxin.
    Theoret JR; Li J; Navarro MA; Garcia JP; Uzal FA; McClane BA
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29038129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic evaluation of membrane-camouflaged nanoparticles in neutralizing Clostridium perfringens ε-toxin.
    Xu J; Li D; Kang L; Liu T; Huang J; Li J; Lv J; Wang J; Gao S; Li Y; Yuan B; Zhao B; Wang J; Xin W
    J Nanobiotechnology; 2023 Mar; 21(1):95. PubMed ID: 36932366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology and Pathogenesis of Brain Lesions Produced by
    Finnie JW; Uzal FA
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012315
    [No Abstract]   [Full Text] [Related]  

  • 19. Amino groups in Clostridium perfringens epsilon prototoxin and epsilon toxin.
    Sakurai J; Nagahama M
    Microb Pathog; 1986 Oct; 1(5):417-23. PubMed ID: 2907772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia.
    Bokori-Brown M; Hall CA; Vance C; Fernandes da Costa SP; Savva CG; Naylor CE; Cole AR; Basak AK; Moss DS; Titball RW
    Vaccine; 2014 May; 32(23):2682-7. PubMed ID: 24709588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.